中华眼底病杂志

中华眼底病杂志

亚临床甲状腺功能减退症与2型糖尿病患者糖尿病视网膜病变相关性研究

查看全文

目的 观察探讨亚临床甲状腺功能减退症(SCH)与2型糖尿病(DM)患者DM视网膜病变(DR)之间的相关性。 方法 792例2型DM(T2DM)住院患者纳入研究。其中,男性448例,女性344例;平均年龄(54.13±13.06)岁;平均DM病程(8.03±6.70)年。根据DR程度、甲状腺功能(甲功)进行分组分析。无DR(无DR组)483例,占61.0%;轻度DR(轻度DR组)240例,占30.3%;重度DR(重度DR组)69例,占8.7%。甲功正常(甲功正常组)725例,占91.5%;SCH(SCH组)67例,占8.5%。比较无DR组、轻度DR组、重度DR组患者之间SCH患病率差异以及甲功正常组、SCH组患者之间DR患病率差异。多因素logistic回归分析SCH与DR的相关性。 结果 无DR组、轻度DR组、重度DR组患者之间SCH患病率比较,差异无统计学意义(χ2=1.823,P=0.402)。SCH组、甲功正常组患者之间DR患病率比较,差异无统计学意义(χ2=1.618,P=0.239)。Logistic回归分析结果显示,SCH与不同程度DR均无相关性[轻度DR:比值比(OR)=1.361,95%可信区间(CI)=0.773~2.399,P=0.286;重度DR:OR=1.326,95%CI=0.520~3.384,P=0.555;DR:OR=1.353,95%CI=0.798~2.294,P=0.261]。 结论 SCH与T2DM患者DR无明显相关性。

Objective To investigate the relationship between subclinical hypothyroidism (SCH) and diabetic retinopathy (DR) in patients with type 2 diabetes mellitus (T2DM). Methods A total of 792 patients of T2DM were enrolled in the study. There were 448 males and 344 females, with an average age of (54.13±13.06) years. The average duration of diabetes was (8.03±6.70) years. The patients were grouped according to the degree of DR and thyroid function. Among them, 483 patients (61.0%) were no DR, 240 patients (30.3%) were mild DR, 69 patients (8.7%) were severe DR. 725 patients (91.5%) were normal thyroid function, 67 patients (8.5%) were SCH. The prevalence of SCH among no DR group, mild DR group and severe DR group was compared. And the prevalence of DR between normal thyroid function group and SCH group was compared. Logistic regression analysis was used to estimate the association between SCH and DR. Results No significant differences among the three groups (no DR group, mild DR group, severe DR group) were found in the prevalence of SCH (χ2=1.823,P=0.402). There were no significant differences in the incidences of DR between normal thyroid function group and SCH group (χ2=1.618,P=0.239). Logistic regression analysis demonstrated that SCH was not significant associated with DR [mild DR: odds ratio (OR)=1.361, 95% confidence interval (CI)=0.773−2.399,P=0.286; severe DR:OR=1.326, 95%CI=0.520−3.384,P=0.555; DR:OR=1.353, 95%CI=0.798−2.294,P=0.261). Conclusion SCH is not significant associated with DR in patients with T2DM.

关键词: 糖尿病视网膜病变/病因学; 甲状腺功能减退症; 糖尿病,2型/并发症

Key words: Diabetic retinopathy/etiology; Hypothyroidism; Diabetes mellitus, type 2/complications

引用本文: 齐琪, 张秋梅, 李春君, 董荣娜, 李金金, 郭娟娟, 时健英, 于德民, 张景云. 亚临床甲状腺功能减退症与2型糖尿病患者糖尿病视网膜病变相关性研究. 中华眼底病杂志, 2017, 33(3): 235-239. doi: 10.3760/cma.j.issn.1005-1015.2017.03.004 复制

登录后 ,请手动点击刷新查看全文内容。 没有账号,
登录后 ,请手动点击刷新查看图表内容。 没有账号,
1. Schroner Z, Lazurova I, Petrovicova J. Autoimmune thyroid diseases in patients with diabetes mellitus[J]. Bratisl Lek Listy, 2008, 109(3): 125-129.
2. Chubb SA, Davis WA, Inman Z, et al. Prevalence and progression of subclinical hypothyroidism in women with type 2 diabetes: the Fremantle Diabetes Study[J]. Clin Endocrinol, 2005, 62(4): 480-486.
3. Radaideh AR, Nusier MK, Amari FL, et al. Thyroid dysfunction in patients with type 2 diabetes mellitus in Jordan[J]. Saudi Med J, 2004, 25(8): 1046-1050.
4. Yang GR, Yang JK, Zhang L, et al. Association between subclinical hypothyroidism and proliferative diabetic retinopathy in type 2 diabetic patients: a case-control study[J]. Tohoku J Exp Med, 2010, 222(4): 303-310.
5. Yang JK, Liu W, Shi J, et al. An association between subclinical hypothyroidism and sight-threatening diabetic retinopathy in type 2 diabetic patients[J]. Diabetes Care, 2010, 33(5): 1018-1020. DOI: 10.2337/dc09-1784.
6. Kim BY, Kim CH, Jung CH, et al. Association between subclinical hypothyroidism and severe diabetic retinopathy in Korean patients with type 2 diabetes[J]. Endocr J, 2010, 58(12): 1065-1070.
7. Chen HS, Wu TE, Jap TS, et al. Subclinical hypothyroidism is a risk factor for nephropathy and cardiovascular diseases in type 2 diabetic patients[J]. Diabetic Med, 2007, 24(12): 1336-1344.
8. Ramis JN, Artigas CF, Santiago MA, et al. Is there a relationship between TSH levels and diabetic retinopathy in the Caucasian population?[J]. Diabetes Res Clin Pract, 2012, 97(3): 45-47. DOI: 10.1016/j.diabres.2012.05.015.
9. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation[J]. J Med Genet, 1999, 37(12): 927-932.
10. Wilkinson CP, Iii FLF, Klein RE, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales[J]. Ophthalmology, 2003, 110(9): 1677-1682.
11. Türemen EE, Çetinarslan B, Şahin T, et al. Endothelial dysfunction and low grade chronic inflammation in subclinical hypothyroidism due to autoimmune thyroiditis[J]. Endocr J, 2011, 58(5): 349-354.
12. Gao CX, Yang B, Guo Q, et al. High thyroid-stimulating hormone level is associated with the risk of developing atherosclerosis in subclinical hypothyroidism[J]. Horm Metab Res, 2015, 47(3): 220-224. DOI: 10.1055/s-0034-1394370.
13. Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction[J]. Endocr Rev, 2008, 29(1): 76-131.
14. Tian L, Gao C, Jing L, et al. Increased carotid arterial stiffness in subclinical hypothyroidism[J]. Eur J Intern Med, 2010, 21(6): 560-563.
15. Popescu T, Moţa M. Dyslipidemia and hypertension in patients with type 2 diabetes and retinopathy[J]. Rom J Intern Med, 2009, 47(3): 235-241.
16. Volanakis JE. Human C-reactive protein: expression, structure, and function[J]. Mol Immunol, 2001, 38(2-3): 189-197.
17. Aksoy DY, Cinar N, Harmanci A, et al. Serum resistin and high sensitive CRP levels in patients with subclinical hypothyroidism before and after L-thyroxine therapy[J]. Med Sci Monit, 2013, 19: 210-215. DOI: 10.12659/MSM.883847.
18. Nik MHS, Darabi M, Ziaee A, et al. Serum Phospholipase A2-ⅡA, hs-CRP, and lipids in women with subclinical hypo-thyroidism[J/OL]. Int J Endocrinol Metab, 2014, 12(3) : E16967 [2014-06-10]. . DOI: 10.5812/ijem.16967. [published online ahead of print].
19. Sasongko MB, Wong TY, Jenkins AJ, et al. Circulating markers of inflammation and endothelial function, and their relationship to diabetic retinopathy[J]. Diabetic Med, 2015, 32(5): 686-691. DOI: 10.1111/dme.12640.
20. Mcdermott MT, Ridgway EC. Subclinical hypothyroidism is mild thyroid failure and should be treated[J]. J Clin Endocrinol Metab, 2001, 86(10): 4585-4590.
21. Cho HC. The relationship among homocysteine, bilirubin, and diabetic retinopathy[J]. Diabetes Metab J, 2011, 35(6): 595-601. DOI: 10.4093/dmj.2011.35.6.595.
22. Maeda M, Yamamoto I, Fujio Y, et al. Homocysteine induces vascular endothelial growth factor expression in differentiated THP-1 macrophages[J]. Biochim Biophys Acta, 2003, 1623(1): 41-46.
23. Maratou E, Hadjidakis DJ, Kollias A, et al. Studies of insulin resistance in patients with clinical and subclinical hypothyroidism[J]. Eur J Endocrinol, 2009, 160(5): 785-790. DOI: 10.1530/EJE-08-0797.
24. Park CY, Park SE, Bae JC, et al. Prevalence of and risk factors for diabetic retinopathy in Koreans with type Ⅱdiabetes: baseline characteristics of Seoul Metropolitan City-Diabetes Prevention Program (SMC-DPP) participants[J]. Br J Ophthalmol, 2012, 96(96): 151-155.